Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial — BMC2012  

Humerus Fracture Displaced Proximal Clinical Trial

Official title: Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures

Status Completed

Clinical Trial Summary

In the present phase-I clinical trial we investigate safety and feasibility of an augmentation with preoperatively isolated autologous BMC cells seeded onto ß-TCP in combination with an angle stable fixation (Philos plate®) for the therapy of proximal humeral fractures.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Humeral Fractures
• Humerus Fracture Displaced Proximal

• NCT number: NCT02153372
• Study type: Interventional
• Source: Goethe University
• Status: Completed
• Phase: Phase 1
• Start date: July 2013
• Completion date: September 2014